Gudrun Hager

444 total citations
14 papers, 354 citations indexed

About

Gudrun Hager is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Gudrun Hager has authored 14 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Gudrun Hager's work include RNA modifications and cancer (4 papers), Cancer-related Molecular Pathways (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Gudrun Hager is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related Molecular Pathways (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Gudrun Hager collaborates with scholars based in Austria, Germany and Belgium. Gudrun Hager's co-authors include Robert Zeillinger, Dan Cacsire Castillo‐Tong, P Speiser, Michael Formanek, J. Kornfehl, Birgit Knerer, Sven� Mahner, Elena Ioana Braicu, Jalid Sehouli and Dietmar Pils and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Biochemistry and European Journal of Cancer.

In The Last Decade

Gudrun Hager

13 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gudrun Hager Austria 11 171 110 109 53 44 14 354
Dongyi Wan China 10 326 1.9× 153 1.4× 146 1.3× 33 0.6× 44 1.0× 16 481
Martin Hellriegel Germany 8 227 1.3× 104 0.9× 62 0.6× 20 0.4× 30 0.7× 15 372
Dilys T.H. Leung Australia 9 177 1.0× 77 0.7× 110 1.0× 18 0.3× 53 1.2× 10 340
Anjali Geethadevi United States 9 190 1.1× 79 0.7× 102 0.9× 15 0.3× 47 1.1× 17 304
Kui Jiang China 10 182 1.1× 98 0.9× 90 0.8× 19 0.4× 66 1.5× 23 330
Ross Wanner United States 6 266 1.6× 89 0.8× 197 1.8× 25 0.5× 18 0.4× 13 365
Chenggong Sun China 14 223 1.3× 103 0.9× 163 1.5× 32 0.6× 66 1.5× 18 430
Kyusam Choi South Korea 7 223 1.3× 84 0.8× 77 0.7× 44 0.8× 34 0.8× 8 330
Shannon E. Muir United States 6 215 1.3× 155 1.4× 76 0.7× 17 0.3× 15 0.3× 7 399
Hirosumi Tamura Japan 8 98 0.6× 94 0.9× 56 0.5× 14 0.3× 42 1.0× 12 298

Countries citing papers authored by Gudrun Hager

Since Specialization
Citations

This map shows the geographic impact of Gudrun Hager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gudrun Hager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gudrun Hager more than expected).

Fields of papers citing papers by Gudrun Hager

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gudrun Hager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gudrun Hager. The network helps show where Gudrun Hager may publish in the future.

Co-authorship network of co-authors of Gudrun Hager

This figure shows the co-authorship network connecting the top 25 collaborators of Gudrun Hager. A scholar is included among the top collaborators of Gudrun Hager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gudrun Hager. Gudrun Hager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Meshcheryakova, Anastasia, Martin Svoboda, Markus Jaritz, et al.. (2019). Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian Cancer. Computational and Structural Biotechnology Journal. 17. 537–560. 21 indexed citations
2.
Svoboda, Martin, Anastasia Meshcheryakova, Georg Heinze, et al.. (2016). AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer. BMC Genomics. 17(1). 643–643. 12 indexed citations
3.
Hager, Gudrun, Wolfgang Holnthoner, Susanne Wolbank, et al.. (2013). Three specific antigens to isolate endothelial progenitor cells from human liposuction material. Cytotherapy. 15(11). 1426–1435. 24 indexed citations
4.
Pils, Dietmar, Anna Bachmayr-Heyda, Katharina Auer, et al.. (2013). Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients – A study of the OVCAD consortium. European Journal of Cancer. 50(1). 99–110. 50 indexed citations
5.
Pils, Dietmar, Dan Cacsire Castillo‐Tong, Gudrun Hager, et al.. (2013). A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium. BMC Cancer. 13(1). 178–178. 30 indexed citations
6.
Pils, Dietmar, Gudrun Hager, Dan Cacsire Castillo‐Tong, et al.. (2012). Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of theOVCADConsortium. Cancer Science. 103(7). 1334–1341. 51 indexed citations
7.
Eulenburg, Christine zu, Elena Ioana Braicu, Jalid Sehouli, et al.. (2012). Treatment reality in elderly patients with advanced ovarian cancer: A prospective analysis of the OVCAD consortium.. Journal of Clinical Oncology. 30(15_suppl). 5058–5058.
8.
Königsberg, Robert, Margit Gneist, Georg Pfeiler, et al.. (2010). Circulating tumor cells in metastatic colorectal cancer: Efficacy and feasibility of different enrichment methods. Cancer Letters. 293(1). 117–123. 49 indexed citations
9.
Gedlicka, Claudia, Gudrun Hager, Martina Weißenböck, et al.. (2006). 1,25(OH)2Vitamin D3 induces elevated expression of the cell cycle inhibitor p18 in a squamous cell carcinoma cell line of the head and neck. Journal of Oral Pathology and Medicine. 35(8). 472–478. 25 indexed citations
10.
Hager, Gudrun, Dan Cacsire Castillo‐Tong, Günther A. Rezniczek, et al.. (2005). The use of a panel of monoclonal antibodies to enrich circulating breast cancer cells facilitates their detection. Gynecologic Oncology. 98(2). 211–216. 22 indexed citations
11.
Hager, Gudrun, J. Kornfehl, Birgit Knerer, Guenter Weigel, & Michael Formanek. (2004). Molecular analysis of p21 promoter activity isolated from squamous carcinoma cell lines of the head and neck under the influence of 1,25(OH)2vitamin D3and its analogs. Acta Oto-Laryngologica. 124(1). 90–96. 22 indexed citations
12.
Kornfehl, J., Gudrun Hager, Claudia Gedlicka, & Michael Formanek. (2002). Ethanol Decreases Negative Cell-cycle-regulating Proteins in a Head and Neck Squamous Cell Carcinoma Cell Line. Acta Oto-Laryngologica. 122(3). 338–342. 6 indexed citations
13.
Hager, Gudrun, Michael Formanek, Claudia Gedlicka, Birgit Knerer, & J. Kornfehl. (2001). Ethanol Decreases Expression of p21 and Increases Hyperphosphorylated pRb in Cell Lines of Squamous Cell Carcinomas of the Head and Neck. Alcoholism Clinical and Experimental Research. 25(4). 496–501. 4 indexed citations
14.
Weber, Viktoria, Andreas Wernitznig, Gudrun Hager, et al.. (1997). Purification and Nucleic‐Acid‐Binding Properties of a Saccharomyces Cerevisiae Protein Involved in the Control of Ploidy. European Journal of Biochemistry. 249(1). 309–317. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026